Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.062 AUD | -1.59% | -4.62% | +181.82% |
Apr. 30 | Nyrada's NYR-BI03 Being Studied For Potential in Traumatic Brain Injury | MT |
Apr. 18 | Transcript : Nyrada Inc., Q3 2024 Earnings Call, Apr 18, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+181.82% | 7.38M | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- NYR Stock
- News Nyrada Inc.
- Nyrada Completes Preclinical Studies on Cholesterol Lowering Medication